SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that President and Chief Executive Officer, John L. Higgins and Vice President of Discovery Research, Dr. Martin Meglasson will both present at the BIO CEO and Investor Conference on Monday, February 9, 2009, at 9:00 a.m. Eastern time (6:00 a.m. Pacific). The conference takes place at the Waldorf-Astoria Hotel in New York City.
